OBJECTIVES: We aimed to compare various methods for free light chain (fLC) quantitation in cerebrospinal fluid (CSF) and serum and to determine whether quantitative CSF measurements could reliably predict intrathecal fLC synthesis. In addition, we wished to determine the relationship between free kappa and free lambda light chain concentrations in CSF and serum in various disease groups. METHODS: We analysed 166 paired CSF and serum samples by at least one of the following methods: turbidimetry (Freelite™, SPAPLUS), nephelometry (N Latex FLC™, BN ProSpec), and two different (commercially available and in-house developed) sandwich ELISAs. The results were compared with oligoclonal fLC detected by affinity-mediated immunoblotting after isoelectric focusing. RESULTS: Although the correlations between quantitative methods were good, both proportional and systematic differences were discerned. However, no major differences were observed in the prediction of positive oligoclonal fLC test. Surprisingly, CSF free kappa/free lambda light chain ratios were lower than those in serum in about 75% of samples with negative oligoclonal fLC test. In about a half of patients with multiple sclerosis and clinically isolated syndrome, profoundly increased free kappa/free lambda light chain ratios were found in the CSF. CONCLUSIONS: Our results show that using appropriate method-specific cut-offs, different methods of CSF fLC quantitation can be used for the prediction of intrathecal fLC synthesis. The reason for unexpectedly low free kappa/free lambda light chain ratios in normal CSFs remains to be elucidated. Whereas CSF free kappa light chain concentration is increased in most patients with multiple sclerosis and clinically isolated syndrome, CSF free lambda light chain values show large interindividual variability in these patients and should be investigated further for possible immunopathological and prognostic significance.

Clinic of Neurology University Hospital Ostrava 17 listopadu 1790 708 52 Ostrava Poruba Czech Republic

Institute for Healthcare Disciplines St Elisabeth University of Health and Social Work in Bratislava Palackého 1 P O Box 104 810 00 Bratislava Slovak Republic

Institute of Laboratory Diagnostics University Hospital Ostrava 17 listopadu 1790 708 52 Ostrava Poruba Czech Republic

Zobrazit více v PubMed

Iwashita H, Grunwald F, Bauer H. Double ring formation in single radial immunodiffusion for kappa chains in multiple sclerosis cerebrospinal fluid. J Neurol. 1974; 207: 45–52. PubMed

Duranti F, Pieri M, Centonze D, Buttari F, Bernardini S, Dessi M. Determination of kFLC and K Index in cerebrospinal fluid: A valid alternative to assess intrathecal immunoglobulin synthesis. J Neuroimmunol. 2013; 263: 116–120. 10.1016/j.jneuroim.2013.07.006 PubMed DOI

Hassan-Smith G, Durant L, Tsentemeidou A, Assi LK, Faint JM, Kalra S, et al. High sensitivity and specificity of elevated cerebrospinal fluid kappa free light chains in suspected multiple sclerosis. J Neuroimmunol. 2014; 276: 175–179. 10.1016/j.jneuroim.2014.08.003 PubMed DOI

Makshakov G, Nazarov V, Kochetova O, Surkova E, Lapin S, Evdoshenko E. Diagnostic and prognostic value of the cerebrospinal fluid concentration of immunoglobulin free light chains in clinically isolated syndrome with conversion to multiple sclerosis. PloS ONE 2015, November 25, 10.1371/journal.pone.0143375 PubMed DOI PMC

Pieri M, Duranti F, Centonze D, Buttari F, Bernardini S, Dessi M. K Index in cerebrospinal fluid: a valid tool in multiple sclerosis diagnosis. Riv Ital Med Lab. 2014; 10: 167–171.

Presslauer S, Milosavljevic D, Bruecke T, Bayer P, Huebl W. Elevated levels of kappa free light chains in CSF support the diagnosis of multiple sclerosis. J Neurol. 2008; 255: 1508–1514. 10.1007/s00415-008-0954-z PubMed DOI

Presslauer S, Milosavljevic D, Huebl W, Parigger S, Schneider-Koch G, Bruecke T. Kappa free light chains: Diagnostic and prognostic relevance in MS and CIS. PLoS One 2014, 9, e89945 10.1371/journal.pone.0089945 PubMed DOI PMC

Presslauer S, Milosavljevic D, Huebl W, Aboulenein-Djamshidian A, Krugluger W, Deisenhammer F, et al. Validation of kappa free light chains as a diagnostic biomarker in multiple sclerosis and clinically isolated syndrome: A multicenter study. Mult Scler J. 2015, published online before print Jul 21, 10.1177/1352458515594044 PubMed DOI

Senel M, Tumani H, Lauda F, Presslauer S, Mojib-Yezdani R, Otto M, et al. Cerebrospinal fluid immunoglobulin kappa light chain in clinically isolated syndrome and multiple sclerosis. PloS One 2014; 9, e88680, 10.1371/journal.pone.0088680 PubMed DOI PMC

Villar LM, Espiño M, Costa-Frossard L, Muriel A, Jiménez J, Álvarez-Cermeño JC. High levels of cerebrospinal fluid free kappa chains predict conversion to multiple sclerosis. Clin. Chim. Acta 2012; 413: 1813–1816. 10.1016/j.cca.2012.07.007 PubMed DOI

Bracco F, Gallo P, Menna R, Battistin L, Tavolato B. Free light chains in the CSF in multiple sclerosis. J. Neurol. 1987; 234: 303–307. PubMed

Gallo P, Tavolato B, Bergenbrant S., Sidén Å. Immunoglobulin light chain patterns in the cerebrospinal fluid. A study with special reference to the occurrence of free light chains in cerebrospinal fluid with and without oligoclonal immunoglobulin G. J Neurol Sci. 1989; 94: 241–253. PubMed

Krakauer M, Schaldemose Nielsen H, Jensen J, Sellebjerg F . Intrathecal synthesis of free immunoglobulin light chains in multiple sclerosis. Acta Neurol Scand. 1998; 98: 161–165. PubMed

Lamers KJ, de Jong JG, Jongen PJ, Kock-Jansen MJ, Teunesen MA, Prudon-Rosmulder EM. Cerebrospinal fluid free kappa light chains versus IgG findings in neurological disorders: qualitative and quantitative measurements. J Neuroimmunol. 1995; 62: 19–25. PubMed

Rudick RA, Peter DR, Bidlack JM, Knutson MD. Multiple sclerosis: Free light chains in cerebrospinal fluid. Neurology 1985; 35: 1443–1449. PubMed

Sindic CJM, Laterre EC. Oligoclonal free kappa and lambda bands in the cerebrospinal fluid of patients with multiple sclerosis and other neurological diseases. An immunoaffinity-mediated capillary blot study. J Neuroimmunol. 1991; 33: 63–72. PubMed

Vakaet A, Thompson EJ. Free light chains in the cerebrospinal fluid: an indicator of recent immunological stimulation. J Neurol Neurosurg Psychiatry 1985; 48: 995–998. PubMed PMC

DeCarli C, Menegus MA, Rudick RA. Free light chains in multiple sclerosis and infections of the CNS. Neurology 1987; 37: 1334–1338. PubMed

Fagnart OC, Sindic CJM, Laterre C. Free kappa and lambda light chain levels in the cerebrospinal fluid of patients with multiple sclerosis and other neurological diseases. J Neuroimmunol. 1988; 19: 119–132. PubMed

Lolli F, Amaducci L. Measurement of free kappa immunoglobulin light chains in the cerebrospinal fluid by a competitive avidin-biotin ELISA. Clin Chim Acta 1989; 182: 229–234. PubMed

Rudick RA, Pallant A, Bidlack JM, Herndon RM. Free kappa light chains in multiple sclerosis spinal fluid. Ann Neurol. 1986; 20: 63–69. 10.1002/ana.410200111 PubMed DOI

Stanescu GL, Swick AR, Tuohy VK, Rudick RA. Sensitive competitive-binding ELISAs for quantifying free kappa and lambda light chains in cerebrospinal fluid. J Clin Lab Anal. 1991; 5: 206–211. PubMed

Bradwell AR, Carr-Smith HD, Mead GP, Tang LX, Showell PJ, Drayson MT, et al. Highly sensitive automated immunoassay for immunoglobulin free light chains in serum and urine. Clin. Chem. 2001; 47: 673–680. PubMed

Katzmann JA, Clark RJ, Abraham RS, Bryant S, Lymp JF, Bradwell AR, et al. Serum reference intervals and diagnostic ranges for free κ and free λ immunoglobulin light chains: relative sensitivity for detection of monoclonal light chains. Clin Chem. 2002; 48: 1437–1444. PubMed

Dimopoulos M, Kyle R, Fermand JP, Rajkumar SV, San MJ, Chanan-Khan A, et al. Consensus recommendations for standard investigative workup: report on the International Myeloma Workshop Consensus Panel 3. Blood 2011; 117: 4701–4705. 10.1182/blood-2010-10-299529 PubMed DOI

Fischer C, Arneth B, Koehler J, Lotz J, Lackner KJ. Kappa free light chains in cerebrospinal fluid as markers of intrathecal immunoglobulin synthesis. Clin Chem. 2004; 50: 1809–1813. 10.1373/clinchem.2004.033977 PubMed DOI

Desplat-Jégo S, Feuillet L, Pelletier J, Bernard D, Cheriff AA, Boucraut J. Quantification of immunoglobulin free light chains in cerebrospinal fluid by nephelometry. J Clin Immunol. 2005; 25: 338–345. 10.1007/s10875-005-5371-9 PubMed DOI

te Velthuis H, Knop I, Stam P, van den Broek M, Bos HK, Hol S, et al. N Latex FLC–new monoclonal high-performance assays for the determination of free light chain kappa and lambda. Clin Chem Lab Med. 2011; 49: 1323–1332. 10.1515/CCLM.2011.624 PubMed DOI

Nakano T, Miyazaki S, Nagata A. Proposed reference material for human free immunoglobulin light chain measurement. J Immunoass Immunochem. 2006; 27: 129–137. PubMed

Nakano T, Nagata A. ELISAs for free light chains of human immunoglobulins using monoclonal antibodies: comparison of their specificity with available polyclonal antibodies. J Immunol Methods 2003; 275: 9–17. PubMed

Nakano T, Nagata A. ELISAs for free human immunoglobulin light chains in serum: improvement of assay specificity by using two specific antibodies in a sandwich detection method. J Immunol Methods 2004; 293: 183–189. 10.1016/j.jim.2004.08.002 PubMed DOI

Nakano T, Miyazaki S, Takahashi H, Matsumori A, Maruyama T, Komoda T, et al. Immunochemical quantification of free immunoglobulin light chains from an analytical perspective. Clin Chem Lab Med. 2006; 44: 522–532. 10.1515/CCLM.2006.118 PubMed DOI

Kaplan B, Livneh A, Sela BA. Immunoglobulin free light chain dimers in human diseases. TheScientificWorldJOURNAL 2011; 11: 726–735. 10.1100/tsw.2011.65 PubMed DOI PMC

Arneth B, Birklein F. High sensitivity of free lambda and free kappa light chains for detection of intrathecal immunoglobulin synthesis in cerebrospinal fluid. Acta Neurol Scand. 2009; 119: 39–44. 10.1111/j.1600-0404.2008.01058.x PubMed DOI

Zeman D. Quantitation of free kappa light chains in neurological patients. [Diploma Thesis]. Institute of Chemical Technology, Prague 2008, pp. 1–102.

Zeman D, Hradílek P, Švagera Z, Mojžíšková E, Woznicová I, Zapletalová O. Detection of oligoclonal IgG kappa and IgG lambda bands in cerebrospinal fluid and serum with Hevylite™ antibodies. Comparison with the free light chain oligoclonal pattern. Fluids Barriers CNS 2012; 9: 5 (23 February 2012). 10.1186/2045-8118-9-5 PubMed DOI PMC

Zeman D, Hradílek P, Kušnierová P, Píža R, Reguliová K, Woznicová I, et al. Oligoclonal free light chains as markers of intrathecal inflammation. Comparison with oligoclonal IgG. Biomed. Pap. Med. Fac. Univ. Palacky Olomouc Czech Repub. 2015; 159: 104–113. 10.5507/bp.2014.058 PubMed DOI

Byrtusová M. Optimization of the ELISA method for the determination of free light chains in the cerebrospinal fluid. [Master´s Thesis]. St. Elizabeth University of Health and Social Work, Institute for Healthcare Disciplines, Bratislava, 2015: pp. 1–98.

Zeman D, Kušnierová P, Bartoš V, Hradílek P, Kurková B, Zapletalová O. Quantitation of free light chains in the cerebrospinal fluid reliably predicts their intrathecal synthesis. Ann Clin Biochem. 2016; 53: 174–6. 10.1177/0004563215579110 PubMed DOI

Teunissen C, Menge T, Altintas A, Álvarez-Cermeño JC, Bertolotto A, Berven FS, et al. Consensus definitions and application guidelines for control groups in cerebrospinal fluid biomarker studies in multiple sclerosis. Mult Scler 2013, 19: 1802–1809. 10.1177/1352458513488232 PubMed DOI

Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol. 2011; 69: 292–302. 10.1002/ana.22366 PubMed DOI PMC

Reiber H. External quality assessment in clinical neurochemistry: Survey of analysis for cerebrospinal fluid (CSF) proteins based on CSF/Serum quotients. Clin Chem. 1995; 41: 256–263. PubMed

Reiber H. Free light chains in CSF–pushing a method with biased interpretations. Acta Neurol Scand. 2009; 12: 445–446. PubMed

Kaplan B, Aizenbud BM, Golderman S, Yaskariev R, Sela BA. Free light chain monomers in the diagnosis of multiple sclerosis. J. Neuroimmunol. 2010; 229: 263–271. 10.1016/j.jneuroim.2010.09.002 PubMed DOI

Kaplan B, Golderman S, Yahalom G, Yeskaraev R, Ziv T, Aizenbud BM, et al. Free light chain monomer-dimer patterns in the diagnosis of multiple sclerosis. J Immunol Methods 2013; 390: 74–80. 10.1016/j.jim.2013.01.010 PubMed DOI

Luning Prak ET, Monestier M, Eisenberg RA. B cell receptor editing in tolerance and autoimmunity. Ann N Y Acad Sci. 2011; 1217: 96–121. 10.1111/j.1749-6632.2010.05877.x PubMed DOI PMC

Sukumar S, Schlissel MS. 2011. Receptor editing as a mechanism of B cell tolerance. J Immunol 2011; 186: 1301–1302. 10.4049/jimmunol.1090129 PubMed DOI

Monson NL, Brezinschek HP, Brezinschek RI, Mobley A, Vaughan GK, Frohman EM, et al. Receptor revision and atypical mutational characteristics in clonally expanded B cells from the cerebrospinal fluid of recently diagnosed multiple sclerosis patients. J Neuroimmunol. 2005; 158: 170–181. 10.1016/j.jneuroim.2004.04.022 PubMed DOI

Reiber H. Flow rate of cerebrospinal fluid (CSF)–a concept common to normal blood-CSF barrier function and to dysfunction in neurological diseases. J Neurol Sci. 1994; 122: 189–203. PubMed